Datasets:
ticker large_stringclasses 498
values | fy int64 2.02k 2.03k | topic large_stringclasses 13
values | rank int64 1 3 | chunk_id large_stringlengths 18 23 | pid int64 0 126k | sector large_stringclasses 11
values | rrf float64 0.02 0.03 | off_topic bool 2
classes | polarity_evidence large_stringlengths 0 731 | polarity int64 -2 2 | magnitude_evidence large_stringlengths 0 468 | magnitude int64 0 3 | realization_evidence large_stringlengths 0 515 | realization int64 0 2 | uncertainty_evidence large_stringlengths 0 588 | uncertainty int64 0 3 | specificity_evidence large_stringlengths 0 554 | specificity int64 0 2 | model large_stringclasses 1
value | usd float64 0 0 | item large_stringclasses 2
values | filing_date large_stringdate 2019-02-21 00:00:00 2026-10-09 00:00:00 | report_date large_stringdate 2019-01-27 00:00:00 2026-09-03 00:00:00 | accession large_stringlengths 20 20 | names_topic bool 2
classes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | 2,019 | China | 1 | A_10-K_2019_1A_0002 | 0 | Health Care | 0.032522 | false | could adversely affect our results of operations; tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; could have a material adverse effect | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; Tariffs recently announced and implemented | 1 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000143 | 1A | 2019-12-19 | 2019-10-31 | 0001090872-19-000022 | true |
A | 2,019 | China | 2 | A_10-K_2019_1A_0006 | 1 | Health Care | 0.031545 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.00016 | 1A | 2019-12-19 | 2019-10-31 | 0001090872-19-000022 | false | |||||
A | 2,019 | China | 3 | A_10-K_2019_1A_0005 | 2 | Health Care | 0.031514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000139 | 1A | 2019-12-19 | 2019-10-31 | 0001090872-19-000022 | false | |||||
A | 2,020 | China | 1 | A_10-K_2020_1A_0004 | 3 | Health Care | 0.032787 | false | Future tariffs and tariffs already implemented could have negative impact on our business | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs already implemented | 1 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000122 | 1A | 2020-12-18 | 2020-10-31 | 0001090872-20-000020 | true |
A | 2,020 | China | 2 | A_10-K_2020_1A_0007 | 4 | Health Care | 0.032002 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000152 | 1A | 2020-12-18 | 2020-10-31 | 0001090872-20-000020 | false | |||||
A | 2,020 | China | 3 | A_10-K_2020_1A_0009 | 5 | Health Care | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000112 | 1A | 2020-12-18 | 2020-10-31 | 0001090872-20-000020 | false | |||||
A | 2,021 | China | 1 | A_10-K_2021_1A_0004 | 6 | Health Care | 0.032787 | false | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; Future tariffs and tariffs already implemented could have negative impact on our business | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; tariffs already implemented | 2 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000146 | 1A | 2021-12-17 | 2021-10-31 | 0001090872-21-000027 | true |
A | 2,021 | China | 2 | A_10-K_2021_1A_0007 | 7 | Health Care | 0.031514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000092 | 1A | 2021-12-17 | 2021-10-31 | 0001090872-21-000027 | false | |||||
A | 2,021 | China | 3 | A_10-K_2021_1A_0009 | 8 | Health Care | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000138 | 1A | 2021-12-17 | 2021-10-31 | 0001090872-21-000027 | false | |||||
A | 2,022 | China | 1 | A_10-K_2022_1A_0004 | 9 | Health Care | 0.032787 | false | changes in diplomatic and trade relationships; tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; political and trade uncertainties in the greater China region | -1 | could have a material adverse effect on our business, results of operations and financial condition | 2 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; tariffs already implemented | 1 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000152 | 1A | 2022-12-21 | 2022-10-31 | 0001090872-22-000026 | true |
A | 2,022 | China | 2 | A_10-K_2022_1A_0007 | 10 | Health Care | 0.032002 | false | China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data | -1 | 0 | China's Personal Information Protection Law and Data Security Law, apply to our activities | 1 | Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000246 | 1A | 2022-12-21 | 2022-10-31 | 0001090872-22-000026 | true | |
A | 2,022 | China | 3 | A_10-K_2022_1A_0009 | 11 | Health Care | 0.03125 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000157 | 1A | 2022-12-21 | 2022-10-31 | 0001090872-22-000026 | false | |||||
A | 2,023 | China | 1 | A_10-K_2023_1A_0002 | 12 | Health Care | 0.032787 | false | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; Future tariffs and tariffs already implemented could have negative impact on our business | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | the scope and duration of which, if implemented, remains uncertain | 2 | the tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000143 | 1A | 2023-12-20 | 2023-10-31 | 0001090872-23-000020 | true |
A | 2,023 | China | 2 | A_10-K_2023_1A_0007 | 13 | Health Care | 0.031514 | false | China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data | -1 | 0 | China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data | 1 | Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000255 | 1A | 2023-12-20 | 2023-10-31 | 0001090872-23-000020 | true | |
A | 2,023 | China | 3 | A_10-K_2023_1A_0009 | 14 | Health Care | 0.031498 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2023-12-20 | 2023-10-31 | 0001090872-23-000020 | false | |||||
A | 2,024 | China | 1 | A_10-K_2024_1A_0002 | 15 | Health Care | 0.032787 | false | Future tariffs and tariffs already implemented could have negative impact on our business; tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; tariffs already implemented | 2 | the scope and duration of which, if implemented, remains uncertain | 3 | the tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000142 | 1A | 2024-12-20 | 2024-10-31 | 0001090872-24-000049 | true |
A | 2,024 | China | 2 | A_10-K_2024_1A_0017 | 16 | Health Care | 0.031746 | false | China's Data Security Law | -1 | 0 | with similar applicable requirements under the EU's NIS2 Directive and China's Data Security Law | 2 | 0 | China's Data Security Law | 2 | claude-haiku-5-5 | 0.000073 | 1A | 2024-12-20 | 2024-10-31 | 0001090872-24-000049 | true | ||
A | 2,024 | China | 3 | A_10-K_2024_1A_0007 | 17 | Health Care | 0.031514 | false | Global privacy laws, including ... China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data ... could harm our results of operations | -1 | 0 | China's Personal Information Protection Law and Data Security Law, apply to our activities | 1 | Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000243 | 1A | 2024-12-20 | 2024-10-31 | 0001090872-24-000049 | true | |
A | 2,025 | China | 1 | A_10-K_2025_1A_0001 | 18 | Health Care | 0.032787 | false | tariffs and trade policies by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; trade war and retaliatory measures could have a material adverse effect | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs already implemented; tariffs and trade policies by the U.S. government on various imports from China | 1 | additional tariffs, the scope and duration of which, if implemented, remain uncertain | 3 | tariffs and trade policies by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000145 | 1A | 2025-12-22 | 2025-10-31 | 0001090872-25-000087 | true |
A | 2,025 | China | 2 | A_10-K_2025_1A_0003 | 19 | Health Care | 0.031746 | false | tariffs, sanctions, and export controls, may restrict our ability to ship products globally; Failure to comply with these regulations could result in penalties, loss of export privileges | -1 | could result in significant costs and require modifications in the way we and our customers conduct business | 1 | The rapid increase in new government regulations, including tariffs and proposed tariffs | 1 | could result in significant costs; could affect our revenue; may restrict our ability to ship products globally | 2 | tariffs, sanctions, and export controls; loss of export privileges | 1 | claude-haiku-5-5 | 0.00014 | 1A | 2025-12-22 | 2025-10-31 | 0001090872-25-000087 | false |
A | 2,025 | China | 3 | A_10-K_2025_1A_0007 | 20 | Health Care | 0.031281 | false | could impose significant limitations and increase our cost of providing our products and services where we process personal data and could harm our results of operations | -1 | 0 | China's Personal Information Protection Law and Data Security Law, the California Consumer Privacy Act and Brazil's Lei Geral de Protecao de Dados, apply to our activities | 1 | could impose significant limitations and increase our cost of providing our products and services where we process personal data and could harm our results of operations and expose us to significant fines | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000253 | 1A | 2025-12-22 | 2025-10-31 | 0001090872-25-000087 | true | |
AAPL | 2,019 | China | 1 | AAPL_10-K_2019_1A_0012 | 21 | Information Technology | 0.032787 | false | trade tensions have led to a series of tariffs imposed by the U.S. on imports from China. Tariffs increase the cost of the Company's products | -1 | These increased costs adversely impact the gross margin that the Company earns on its products. | 2 | trade tensions have led to a series of tariffs imposed by the U.S. on imports from China | 2 | Political uncertainty surrounding international trade disputes and measures could also have a negative effect on consumer confidence and spending | 2 | a series of tariffs imposed by the U.S. on imports from China | 2 | claude-haiku-5-5 | 0.000137 | 1A | 2019-10-31 | 2019-09-28 | 0000320193-19-000119 | true |
AAPL | 2,019 | China | 2 | AAPL_10-K_2019_7_0006 | 22 | Information Technology | 0.031498 | false | Greater China net sales decreased during 2019 compared to 2018 due primarily to lower iPhone net sales | -1 | Greater China net sales decreased during 2019 compared to 2018 due primarily to lower iPhone net sales, partially offset by higher Wearables, Home and Accessories and Services net sales | 2 | Greater China net sales decreased during 2019 compared to 2018 | 2 | 0 | Greater China net sales decreased during 2019 compared to 2018 due primarily to lower iPhone net sales | 2 | claude-haiku-5-5 | 0.0001 | 7 | 2019-10-31 | 2019-09-28 | 0000320193-19-000119 | true | |
AAPL | 2,019 | China | 3 | AAPL_10-K_2019_1A_0004 | 23 | Information Technology | 0.031281 | false | international trade disputes | -1 | 0 | 0 | could be materially adversely affected | 2 | 0 | claude-haiku-5-5 | 0.000095 | 1A | 2019-10-31 | 2019-09-28 | 0000320193-19-000119 | false | |||
AAPL | 2,020 | China | 1 | AAPL_10-K_2020_1A_0013 | 24 | Information Technology | 0.032787 | false | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions. Tariffs may increase the cost of the Company's products | -1 | These increased costs adversely impact the gross margin that the Company earns on its products | 1 | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | could make the Company's products less competitive and reduce consumer demand | 2 | a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | claude-haiku-5-5 | 0.000157 | 1A | 2020-10-30 | 2020-09-26 | 0000320193-20-000096 | true |
AAPL | 2,020 | China | 2 | AAPL_10-K_2020_1A_0016 | 25 | Information Technology | 0.031514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000155 | 1A | 2020-10-30 | 2020-09-26 | 0000320193-20-000096 | false | |||||
AAPL | 2,020 | China | 3 | AAPL_10-K_2020_1A_0009 | 26 | Information Technology | 0.03125 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000098 | 1A | 2020-10-30 | 2020-09-26 | 0000320193-20-000096 | false | |||||
AAPL | 2,021 | China | 1 | AAPL_10-K_2021_1A_0003 | 27 | Information Technology | 0.032787 | false | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions. Tariffs increase the cost of the Company's products | -1 | These increased costs adversely impact the gross margin that the Company earns on its products. | 1 | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | could make the Company's products less competitive and reduce consumer demand | 2 | a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | claude-haiku-5-5 | 0.000141 | 1A | 2021-10-29 | 2021-09-25 | 0000320193-21-000105 | true |
AAPL | 2,021 | China | 2 | AAPL_10-K_2021_1A_0016 | 28 | Information Technology | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.00015 | 1A | 2021-10-29 | 2021-09-25 | 0000320193-21-000105 | false | |||||
AAPL | 2,021 | China | 3 | AAPL_10-K_2021_1A_0020 | 29 | Information Technology | 0.030798 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000144 | 1A | 2021-10-29 | 2021-09-25 | 0000320193-21-000105 | false | |||||
AAPL | 2,022 | China | 1 | AAPL_10-K_2022_1A_0003 | 30 | Information Technology | 0.032787 | false | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions | -1 | can materially adversely affect the Company's business, particularly if these measures occur in regions where the Company derives a significant portion of its revenues | 2 | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | If disputes and conflicts further escalate in the future, actions by governments in response could be significantly more severe and restrictive and could materially adversely affect the Company's business | 2 | tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions | 2 | claude-haiku-5-5 | 0.00016 | 1A | 2022-10-28 | 2022-09-24 | 0000320193-22-000108 | true |
AAPL | 2,022 | China | 2 | AAPL_10-K_2022_1A_0016 | 31 | Information Technology | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000153 | 1A | 2022-10-28 | 2022-09-24 | 0000320193-22-000108 | false | |||||
AAPL | 2,022 | China | 3 | AAPL_10-K_2022_1A_0002 | 32 | Information Technology | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000145 | 1A | 2022-10-28 | 2022-09-24 | 0000320193-22-000108 | false | |||||
AAPL | 2,023 | China | 1 | AAPL_10-K_2023_1A_0002 | 33 | Information Technology | 0.032787 | false | Restrictions on international trade, such as tariffs and other controls on imports or exports of goods, technology or data, can materially adversely affect the Company's operations and supply chain | -1 | can materially adversely affect the Company's operations and supply chain | 1 | tensions between governments, including the U.S. and China, have in the past led to tariffs and other restrictions being imposed on the Company's business | 2 | If disputes and conflicts further escalate in the future, actions by governments in response could be significantly more severe and restrictive and could materially adversely affect the Company's business | 2 | outsourcing partners located primarily in China mainland, India, Japan, South Korea, Taiwan and Vietnam | 2 | claude-haiku-5-5 | 0.000153 | 1A | 2023-11-03 | 2023-09-30 | 0000320193-23-000106 | true |
AAPL | 2,023 | China | 2 | AAPL_10-K_2023_1A_0015 | 34 | Information Technology | 0.032002 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000158 | 1A | 2023-11-03 | 2023-09-30 | 0000320193-23-000106 | false | |||||
AAPL | 2,023 | China | 3 | AAPL_10-K_2023_1A_0020 | 35 | Information Technology | 0.030798 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000151 | 1A | 2023-11-03 | 2023-09-30 | 0000320193-23-000106 | false | |||||
AAPL | 2,024 | China | 1 | AAPL_10-K_2024_1A_0001 | 36 | Information Technology | 0.032522 | false | Restrictions on international trade... can materially adversely affect the Company's business and supply chain; tensions between governments, including the U.S. and China, have in the past led to tariffs and other restrictions affecting the Company's business | -1 | can materially adversely affect the Company's business and supply chain | 2 | tensions between governments, including the U.S. and China, have in the past led to tariffs and other restrictions affecting the Company's business. If disputes and conflicts further escalate in the future | 1 | If disputes and conflicts further escalate in the future, actions by governments in response could be significantly more severe and restrictive and could materially adversely affect the Company's business | 2 | outsourcing partners located primarily in China mainland, India, Japan, South Korea, Taiwan and Vietnam; tariffs and other controls on imports or exports of goods, technology or data | 2 | claude-haiku-5-5 | 0.000181 | 1A | 2024-11-01 | 2024-09-28 | 0000320193-24-000123 | true |
AAPL | 2,024 | China | 2 | AAPL_10-K_2024_1A_0015 | 37 | Information Technology | 0.032018 | false | the Company's products could be banned, delayed or prohibited from importation, which could materially adversely affect the Company's business | -1 | could materially adversely affect the Company's business, reputation, results of operations and financial condition | 1 | the Company is subject to changing regulations relating to the export and import of its products | 1 | could materially adversely affect; Regulatory changes ... may be announced with little or no advance notice | 2 | the export and import of its products; the Company's products could be banned, delayed or prohibited from importation | 1 | claude-haiku-5-5 | 0.000135 | 1A | 2024-11-01 | 2024-09-28 | 0000320193-24-000123 | false |
AAPL | 2,024 | China | 3 | AAPL_10-K_2024_1A_0006 | 38 | Information Technology | 0.031258 | false | manufacturing or logistics in these locations or transit to final destinations can be disrupted ... trade and other international disputes, geopolitical tensions, or conflict | -1 | Passage is boilerplate on supply risks for China-linked Asia manufacturing; no described China-specific effect beyond general disruption risk | 1 | manufacturing or logistics in these locations ... can be disrupted; Such disruptions could occur in the future | 0 | can be disrupted for a variety of reasons; involve significant risks and uncertainties | 2 | outsourcing partners primarily located in Asia; trade and other international disputes, geopolitical tensions | 1 | claude-haiku-5-5 | 0.00014 | 1A | 2024-11-01 | 2024-09-28 | 0000320193-24-000123 | false |
AAPL | 2,025 | China | 1 | AAPL_10-K_2025_1A_0002 | 39 | Information Technology | 0.032787 | false | can materially adversely affect the Company's business and supply chain | -1 | can materially adversely affect the Company's business and supply chain | 2 | Beginning in the second quarter of 2025, new tariffs were announced on imports to the U.S. ... including additional tariffs on imports from China | 2 | The ultimate impact remains uncertain | 3 | Section 232 of the Trade Expansion Act of 1962 ... imports of semiconductors, semiconductor manufacturing equipment | 2 | claude-haiku-5-5 | 0.000138 | 1A | 2025-10-31 | 2025-09-27 | 0000320193-25-000079 | true |
AAPL | 2,025 | China | 2 | AAPL_10-K_2025_7_0003 | 40 | Information Technology | 0.031754 | false | additional tariffs on imports from China ... several countries have imposed, or threatened to impose, reciprocal tariffs ... can have a material adverse impact on the Company's business | -1 | can have a material adverse impact on the Company's business, results of operations and financial condition | 2 | Beginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China | 1 | The ultimate impact remains uncertain and will depend on several factors | 3 | additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU ... Section 232 of the Trade Expansion Act of 1962 ... imports of semiconductors | 2 | claude-haiku-5-5 | 0.000131 | 7 | 2025-10-31 | 2025-09-27 | 0000320193-25-000079 | true |
AAPL | 2,025 | China | 3 | AAPL_10-K_2025_1A_0013 | 41 | Information Technology | 0.031258 | false | the Company is subject to changing regulations relating to the export and import of its products. ... products could be banned, delayed or prohibited from importation | -1 | could materially adversely affect the Company's business | 0 | For example, the Company is subject to changing regulations relating to the export and import of its products. | 0 | the Company's products could be banned, delayed or prohibited from importation | 2 | anticorruption; import, export and trade | 1 | claude-haiku-5-5 | 0.000126 | 1A | 2025-10-31 | 2025-09-27 | 0000320193-25-000079 | false |
ABBV | 2,019 | China | 1 | ABBV_10-K_2019_1A_0009 | 42 | Health Care | 0.032266 | false | international trade disruptions or disputes, including in connection with the ongoing trade negotiations between the United States and China | -1 | 1 | ongoing trade negotiations between the United States and China | 1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on AbbVie's revenues and profitability. | 2 | international trade disruptions or disputes, including in connection with the ongoing trade negotiations between the United States and China | 1 | claude-haiku-5-5 | 0.00013 | 1A | 2020-02-21 | 2019-12-31 | 0001551152-20-000007 | true | |
ABBV | 2,019 | China | 2 | ABBV_10-K_2019_1A_0008 | 43 | Health Care | 0.031319 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000109 | 1A | 2020-02-21 | 2019-12-31 | 0001551152-20-000007 | false | |||||
ABBV | 2,019 | China | 3 | ABBV_10-K_2019_1A_0006 | 44 | Health Care | 0.031025 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000099 | 1A | 2020-02-21 | 2019-12-31 | 0001551152-20-000007 | false | |||||
ABBV | 2,020 | China | 1 | ABBV_10-K_2020_1A_0010 | 45 | Health Care | 0.032787 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000134 | 1A | 2021-02-19 | 2020-12-31 | 0001551152-21-000008 | false | |||||
ABBV | 2,020 | China | 2 | ABBV_10-K_2020_1A_0006 | 46 | Health Care | 0.031746 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000099 | 1A | 2021-02-19 | 2020-12-31 | 0001551152-21-000008 | false | |||||
ABBV | 2,020 | China | 3 | ABBV_10-K_2020_1A_0009 | 47 | Health Care | 0.030331 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000135 | 1A | 2021-02-19 | 2020-12-31 | 0001551152-21-000008 | false | |||||
ABBV | 2,021 | China | 1 | ABBV_10-K_2021_1A_0011 | 48 | Health Care | 0.031545 | false | multiple legal and regulatory requirements that are subject to change and that could restrict AbbVie's ability to manufacture, market and sell its products; Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect | -1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on AbbVie's revenues and profitability | 0 | could restrict AbbVie's ability; could be adversely affected | 0 | may, individually or in the aggregate, have a material adverse effect | 2 | trade protection measures and import or export licensing requirements; international trade disruptions or disputes; United Kingdom's exit from the European Union | 1 | claude-haiku-5-5 | 0.000144 | 1A | 2022-02-18 | 2021-12-31 | 0001551152-22-000007 | false |
ABBV | 2,021 | China | 2 | ABBV_10-K_2021_1A_0010 | 49 | Health Care | 0.031099 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000125 | 1A | 2022-02-18 | 2021-12-31 | 0001551152-22-000007 | false | |||||
ABBV | 2,021 | China | 3 | ABBV_10-K_2021_1A_0007 | 50 | Health Care | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000131 | 1A | 2022-02-18 | 2021-12-31 | 0001551152-22-000007 | false | |||||
ABBV | 2,022 | China | 1 | ABBV_10-K_2022_1A_0011 | 51 | Health Care | 0.032258 | false | international trade disruptions or disputes; trade protection measures and import or export licensing requirements | -1 | 0 | 0 | 2 | 0 | claude-haiku-5-5 | 0.000097 | 1A | 2023-02-17 | 2022-12-31 | 0001551152-23-000011 | false | ||||
ABBV | 2,022 | China | 2 | ABBV_10-K_2022_7_0003 | 52 | Health Care | 0.031778 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000108 | 7 | 2023-02-17 | 2022-12-31 | 0001551152-23-000011 | false | |||||
ABBV | 2,022 | China | 3 | ABBV_10-K_2022_1A_0007 | 53 | Health Care | 0.030579 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2023-02-17 | 2022-12-31 | 0001551152-23-000011 | false | |||||
ABBV | 2,023 | China | 1 | ABBV_10-K_2023_1A_0011 | 54 | Health Care | 0.032266 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000134 | 1A | 2024-02-20 | 2023-12-31 | 0001551152-24-000011 | false | |||||
ABBV | 2,023 | China | 2 | ABBV_10-K_2023_1A_0010 | 55 | Health Care | 0.031099 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000136 | 1A | 2024-02-20 | 2023-12-31 | 0001551152-24-000011 | false | |||||
ABBV | 2,023 | China | 3 | ABBV_10-K_2023_1A_0008 | 56 | Health Care | 0.030536 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000129 | 1A | 2024-02-20 | 2023-12-31 | 0001551152-24-000011 | false | |||||
ABBV | 2,024 | China | 1 | ABBV_10-K_2024_1A_0012 | 57 | Health Care | 0.031545 | false | The international nature of AbbVie's business subjects it to additional business risks that may cause its revenue and profitability to decline | -1 | 0 | Net revenues outside of the United States made up approximately 24% of AbbVie's total net revenues in 2024 | 0 | may cause its revenue and profitability to decline | 2 | Passage mentions China only generically within a list of international risks; no China-specific details such as named regulations, counterparties, or amounts | 0 | claude-haiku-5-5 | 0.000126 | 1A | 2025-02-14 | 2024-12-31 | 0001551152-25-000020 | false | |
ABBV | 2,024 | China | 2 | ABBV_10-K_2024_1A_0011 | 58 | Health Care | 0.030679 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2025-02-14 | 2024-12-31 | 0001551152-25-000020 | false | |||||
ABBV | 2,024 | China | 3 | ABBV_10-K_2024_1A_0009 | 59 | Health Care | 0.030536 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000129 | 1A | 2025-02-14 | 2024-12-31 | 0001551152-25-000020 | false | |||||
ABBV | 2,025 | China | 1 | ABBV_10-K_2025_1A_0012 | 60 | Health Care | 0.032522 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000155 | 1A | 2026-02-20 | 2025-12-31 | 0001551152-26-000008 | false | |||||
ABBV | 2,025 | China | 2 | ABBV_10-K_2025_1A_0008 | 61 | Health Care | 0.031099 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000142 | 1A | 2026-02-20 | 2025-12-31 | 0001551152-26-000008 | false | |||||
ABBV | 2,025 | China | 3 | ABBV_10-K_2025_1A_0011 | 62 | Health Care | 0.030835 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000126 | 1A | 2026-02-20 | 2025-12-31 | 0001551152-26-000008 | false | |||||
ABNB | 2,020 | China | 1 | ABNB_10-K_2020_1A_0034 | 63 | Consumer Discretionary | 0.032787 | false | could materially adversely affect our brand, reputation, business, results of operations, and financial condition | -1 | could materially adversely affect our brand, reputation, business | 2 | Failure to comply with such requests or other requirements as interpreted by government agencies may lead to impairment or disruption to our business | 0 | it is uncertain what obligations will apply to us in the future; there are substantial uncertainties as to its ultimate interpretation and whether it applies to us | 2 | China's first cybersecurity law ("CSL") took effect in June 2017; "critical information infrastructure"; VIE and wholly-foreign owned entity; data localization requirements | 2 | claude-haiku-5-5 | 0.000157 | 1A | 2021-02-26 | 2020-12-31 | 0001559720-21-000010 | true |
ABNB | 2,020 | China | 2 | ABNB_10-K_2020_1A_0033 | 64 | Consumer Discretionary | 0.032002 | false | we have invested heavily to expand our operations in China, which is an intensely competitive market ... we may not achieve profitability in that market | -1 | we expect to continue to incur significant expenses to operate our business in China | 2 | we have invested heavily to expand our operations in China | 2 | we may not achieve profitability in that market ... may particularly impact our operations in China | 2 | China's policy towards foreign direct investment; sentiment of the workforce in China; modifications to the way our website, mobile apps ... function in China | 2 | claude-haiku-5-5 | 0.000132 | 1A | 2021-02-26 | 2020-12-31 | 0001559720-21-000010 | true |
ABNB | 2,020 | China | 3 | ABNB_10-K_2020_1A_0073 | 65 | Consumer Discretionary | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000134 | 1A | 2021-02-26 | 2020-12-31 | 0001559720-21-000010 | false | |||||
ABNB | 2,021 | China | 1 | ABNB_10-K_2021_1A_0035 | 66 | Consumer Discretionary | 0.032787 | false | could materially adversely affect our brand, reputation, business, results of operations, and financial condition; we may never achieve profitability or sizable supply penetration in that market | -1 | we will continue to incur significant expenses to operate our business in China | 2 | we will continue to incur significant expenses to operate our business in China; Chinese government has adopted laws, regulations and implementation measures | 1 | At this point, it is uncertain what obligations will apply to us in the future, and we cannot predict what impact these new laws and regulations | 3 | laws, regulations and implementation measures that govern the dissemination of content over the Internet and data processing in China; licenses to operate in China, the blocking of our platform | 2 | claude-haiku-5-5 | 0.00015 | 1A | 2022-02-25 | 2021-12-31 | 0001559720-22-000006 | true |
ABNB | 2,021 | China | 2 | ABNB_10-K_2021_1A_0074 | 67 | Consumer Discretionary | 0.031498 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.00015 | 1A | 2022-02-25 | 2021-12-31 | 0001559720-22-000006 | false | |||||
ABNB | 2,021 | China | 3 | ABNB_10-K_2021_1A_0036 | 68 | Consumer Discretionary | 0.031281 | false | we could be subject to penalties, be forced to cease our operations in China, or be subject to restrictions | -1 | we could be subject to penalties, be forced to cease our operations in China | 2 | if the Chinese government deems that the contractual arrangements ... do not comply | 0 | we could be subject to penalties, be forced to cease our operations in China, or be subject to restrictions in the future | 2 | contractual arrangements with the equity holders of our VIE ... Chinese tax authorities ... related party transaction pricing | 2 | claude-haiku-5-5 | 0.000141 | 1A | 2022-02-25 | 2021-12-31 | 0001559720-22-000006 | true |
ABNB | 2,022 | China | 1 | ABNB_10-K_2022_1A_0021 | 69 | Consumer Discretionary | 0.032787 | false | may particularly impact our operations in China; may lead to impairment or disruption to our business and operations; could materially adversely affect our brand, reputation, business, results of operations | -1 | we may never achieve profitability in that market; could adversely affect our outbound business in China | 2 | we will continue to incur significant expenses to operate our outbound business in China; Failure to comply ... may lead to; could be subject to penalties | 0 | At this point, it is uncertain what obligations will apply to us in the future, and we cannot predict what impact these new laws and regulations | 3 | variable interest entity (VIE) and a wholly-foreign owned entity; laws, regulations, and implementation measures that govern the dissemination of content over the Internet and data processing in China; Executive Orders or trade blacklists | 2 | claude-haiku-5-5 | 0.000164 | 1A | 2023-02-17 | 2022-12-31 | 0001559720-23-000003 | true |
ABNB | 2,022 | China | 2 | ABNB_10-K_2022_1A_0074 | 70 | Consumer Discretionary | 0.032258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000147 | 1A | 2023-02-17 | 2022-12-31 | 0001559720-23-000003 | false | |||||
ABNB | 2,022 | China | 3 | ABNB_10-K_2022_1A_0073 | 71 | Consumer Discretionary | 0.030077 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000122 | 1A | 2023-02-17 | 2022-12-31 | 0001559720-23-000003 | false | |||||
ABNB | 2,023 | China | 1 | ABNB_10-K_2023_1A_0019 | 72 | Consumer Discretionary | 0.032787 | false | we could be subject to penalties, be forced to cease our operations in China, or be subject to restrictions in the future | -1 | we cannot predict what impact these new laws and regulations or the increased costs of compliance, if any, will have on our operations in China | 1 | The Chinese government has adopted laws, regulations, and implementation measures that govern the dissemination of content over the Internet and data processing in China | 1 | it is uncertain what obligations will apply to us in the future, and we cannot predict what impact | 3 | contractual arrangements with the equity holders of our VIE; trade blacklists to ban or limit the use of services provided by Chinese third parties; variable interest entity | 2 | claude-haiku-5-5 | 0.000133 | 1A | 2024-02-16 | 2023-12-31 | 0001559720-24-000006 | true |
ABNB | 2,023 | China | 2 | ABNB_10-K_2023_1A_0018 | 73 | Consumer Discretionary | 0.032258 | false | we will continue to incur significant expenses to operate our outbound business in China, and we may never achieve profitability in that market | -1 | could materially adversely affect our brand, reputation, business, results of operations, and financial condition | 1 | we need to ensure that our business practices in China are compliant with local laws | 1 | could adversely affect our outbound business in China | 2 | We are subject to various requirements and requests from government agencies to share information on users who use services in China through our platform | 2 | claude-haiku-5-5 | 0.000137 | 1A | 2024-02-16 | 2023-12-31 | 0001559720-24-000006 | true |
ABNB | 2,023 | China | 3 | ABNB_10-K_2023_1A_0069 | 74 | Consumer Discretionary | 0.031025 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000111 | 1A | 2024-02-16 | 2023-12-31 | 0001559720-24-000006 | false | |||||
ABNB | 2,024 | China | 1 | ABNB_10-K_2024_1A_0028 | 75 | Consumer Discretionary | 0.032522 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000173 | 1A | 2025-02-13 | 2024-12-31 | 0001559720-25-000010 | false | |||||
ABNB | 2,024 | China | 2 | ABNB_10-K_2024_1A_0024 | 76 | Consumer Discretionary | 0.031258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000141 | 1A | 2025-02-13 | 2024-12-31 | 0001559720-25-000010 | false | |||||
ABNB | 2,024 | China | 3 | ABNB_10-K_2024_1A_0037 | 77 | Consumer Discretionary | 0.030331 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000147 | 1A | 2025-02-13 | 2024-12-31 | 0001559720-25-000010 | false | |||||
ABNB | 2,025 | China | 1 | ABNB_10-K_2025_1A_0039 | 78 | Consumer Discretionary | 0.032522 | false | With regard to China, the regulatory requirements on AI and ML Technologies, export controls and other relevant regulations are still evolving and have ongoing complexity and uncertainty. | -1 | may impact our ability, or require additional resources (which may be substantial), to develop and/or maintain related product features | 1 | are still evolving and have ongoing complexity and uncertainty | 1 | The positions and interpretation of these regulations by the authorities may not align with our interpretation | 2 | With regard to China, the regulatory requirements on AI and ML Technologies, export controls and other relevant regulations | 1 | claude-haiku-5-5 | 0.000134 | 1A | 2026-02-12 | 2025-12-31 | 0001559720-26-000004 | true |
ABNB | 2,025 | China | 2 | ABNB_10-K_2025_1A_0034 | 79 | Consumer Discretionary | 0.032522 | false | Our China-related content: DOJ rule aimed at preventing access by "countries of concern" (including China)... could materially impact our business operations or hinder our ability to grow | -1 | Compliance with the rule may require us to stop or restrict certain data transfers... could materially impact our business operations or hinder our ability to grow our business | 2 | in 2025 the DOJ issued a new rule... has yet to be enforced | 1 | there is a risk that our interpretation of its applicability, scope, and requirements is incorrect, incomplete, or misapplied | 2 | DOJ issued a new rule, to implement Executive Order 14117 aimed at preventing access to "bulk U.S. sensitive personal data" ... by "countries of concern" (including China, Russia, Iran, North Korea, Cuba, and Venezuela) | 2 | claude-haiku-5-5 | 0.000167 | 1A | 2026-02-12 | 2025-12-31 | 0001559720-26-000004 | true |
ABNB | 2,025 | China | 3 | ABNB_10-K_2025_7_0004 | 80 | Consumer Discretionary | 0.030798 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000058 | 7 | 2026-02-12 | 2025-12-31 | 0001559720-26-000004 | false | |||||
ABT | 2,019 | China | 1 | ABT_10-K_2019_1A_0007 | 81 | Health Care | 0.032266 | false | subjects it to additional business risks that may cause its revenue and profitability to decline | -1 | Sales outside of the United States in 2019 made up approximately 64 percent of Abbott's net sales | 1 | Additional risks associated with Abbott's international operations include | 0 | may, individually or in the aggregate, have a material adverse effect | 2 | restrictions on local currency conversion and/or cash extraction; price controls ... the Foreign Corrupt Practices Act and the U.K. Bribery Act | 1 | claude-haiku-5-5 | 0.000134 | 1A | 2020-02-21 | 2019-12-31 | 0001104659-20-023904 | false |
ABT | 2,019 | China | 2 | ABT_10-K_2019_7_0010 | 82 | Health Care | 0.030886 | false | challenging market dynamics in the Greater China infant category; growth in several geographies including China; sales in India and China experienced double-digit growth | 0 | Greater China infant category challenges offset growth; China growth is one of several geographies within emerging markets increasing 7.9 percent; no China-specific size stated | 1 | sales in these key emerging markets increased 7.9 percent in 2019 due to growth in several geographies including China | 2 | 0 | Greater China infant category; China named as key emerging market; Similac and PediaSure in Asia and Latin America | 2 | claude-haiku-5-5 | 0.000146 | 7 | 2020-02-21 | 2019-12-31 | 0001104659-20-023904 | true | |
ABT | 2,019 | China | 3 | ABT_10-K_2019_1A_0001 | 83 | Health Care | 0.030835 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000101 | 1A | 2020-02-21 | 2019-12-31 | 0001104659-20-023904 | false | |||||
ABT | 2,020 | China | 1 | ABT_10-K_2020_1A_0008 | 84 | Health Care | 0.032522 | false | restrictions on local currency conversion and/or cash extraces; trade protection measures, including tariffs; Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on Abbott's revenues and profitability | -1 | Sales outside of the United States in 2020 made up approximately 62 percent of Abbott's net sales | 1 | Additional risks associated with Abbott's international operations include | 0 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect | 2 | changes to international trade agreements; restrictions on local currency conversion; Foreign Corrupt Practices Act and the U.K. Bribery Act | 1 | claude-haiku-5-5 | 0.000144 | 1A | 2021-02-19 | 2020-12-31 | 0001104659-21-025751 | false |
ABT | 2,020 | China | 2 | ABT_10-K_2020_1A_0007 | 85 | Health Care | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2021-02-19 | 2020-12-31 | 0001104659-21-025751 | false | |||||
ABT | 2,020 | China | 3 | ABT_10-K_2020_7_0011 | 86 | Health Care | 0.029907 | false | challenging market dynamics in the infant category in Greater China; growth in several geographies including China | -1 | International Pediatric Nutritional sales decreased 4.1 percent; key emerging markets including China increased 2.6 percent | 1 | sales in these key emerging markets increased 2.6 percent in 2020 due to higher sales in several geographies including China; challenging market dynamics in the infant category in Greater China | 2 | 0 | infant category in Greater China; Similac and PediaSure in various countries in Asia | 2 | claude-haiku-5-5 | 0.000131 | 7 | 2021-02-19 | 2020-12-31 | 0001104659-21-025751 | true | |
ABT | 2,021 | China | 1 | ABT_10-K_2021_1A_0008 | 87 | Health Care | 0.032787 | false | Deterioration in the economic condition and credit quality of certain countries may negatively affect Abbott's results | -1 | 0 | 0 | may negatively affect Abbott's results of operations | 2 | 0 | claude-haiku-5-5 | 0.000105 | 1A | 2022-02-18 | 2021-12-31 | 0001104659-22-025141 | false | |||
ABT | 2,021 | China | 2 | ABT_10-K_2021_1A_0003 | 88 | Health Care | 0.029828 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000102 | 1A | 2022-02-18 | 2021-12-31 | 0001104659-22-025141 | false | |||||
ABT | 2,021 | China | 3 | ABT_10-K_2021_1A_0006 | 89 | Health Care | 0.029514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000098 | 1A | 2022-02-18 | 2021-12-31 | 0001104659-22-025141 | false | |||||
ABT | 2,022 | China | 1 | ABT_10-K_2022_1A_0009 | 90 | Health Care | 0.032522 | false | Deterioration in the economic condition and credit quality of certain countries may negatively affect Abbott's results | -1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on Abbott's revenues and profitability. | 1 | may negatively affect Abbott's results of operations | 0 | may negatively affect; could increase Abbott's collection risk | 2 | Sales outside of the United States in 2022 made up approximately 58 percent of Abbott's net sales; Foreign Corrupt Practices Act and the U.K. Bribery Act | 1 | claude-haiku-5-5 | 0.000135 | 1A | 2023-02-17 | 2022-12-31 | 0001628280-23-004026 | false |
ABT | 2,022 | China | 2 | ABT_10-K_2022_1A_0010 | 91 | Health Care | 0.029727 | false | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000098 | 1A | 2023-02-17 | 2022-12-31 | 0001628280-23-004026 | false | |||||
ABT | 2,022 | China | 3 | ABT_10-K_2022_1A_0004 | 92 | Health Care | 0.02967 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000122 | 1A | 2023-02-17 | 2022-12-31 | 0001628280-23-004026 | false | |||||
ABT | 2,023 | China | 1 | ABT_10-K_2023_1A_0009 | 93 | Health Care | 0.032258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000154 | 1A | 2024-02-16 | 2023-12-31 | 0001628280-24-005348 | false | |||||
ABT | 2,023 | China | 2 | ABT_10-K_2023_1A_0008 | 94 | Health Care | 0.031258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000107 | 1A | 2024-02-16 | 2023-12-31 | 0001628280-24-005348 | false | |||||
ABT | 2,023 | China | 3 | ABT_10-K_2023_1A_0010 | 95 | Health Care | 0.030092 | false | potential penalties or other adverse consequences for violations of anti-corruption, anti-bribery, and other similar laws and regulations, including the Foreign Corrupt Practices Act | -1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on Abbott's revenues and profitability. | 0 | 0 | Events contemplated by these risks may | 2 | Foreign Corrupt Practices Act and the U.K. Bribery Act | 2 | claude-haiku-5-5 | 0.000138 | 1A | 2024-02-16 | 2023-12-31 | 0001628280-24-005348 | false | |
ABT | 2,024 | China | 1 | ABT_10-K_2024_1A_0008 | 96 | Health Care | 0.032787 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000156 | 1A | 2025-02-21 | 2024-12-31 | 0001628280-25-007110 | false | |||||
ABT | 2,024 | China | 2 | ABT_10-K_2024_1A_0007 | 97 | Health Care | 0.032002 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000144 | 1A | 2025-02-21 | 2024-12-31 | 0001628280-25-007110 | false | |||||
ABT | 2,024 | China | 3 | ABT_10-K_2024_1A_0009 | 98 | Health Care | 0.030622 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000087 | 1A | 2025-02-21 | 2024-12-31 | 0001628280-25-007110 | false | |||||
ABT | 2,025 | China | 1 | ABT_10-K_2025_1A_0007 | 99 | Health Care | 0.032787 | false | could negatively affect Abbott's business; could have a negative impact on macroeconomic conditions | -1 | 0 | The U.S. government has imposed tariffs on imports into the U.S., and it may impose additional tariffs in the future | 1 | it is difficult to predict the future implications and consequences of the conflict | 2 | Some countries may retaliate with trade protection measures, including reciprocal tariffs | 1 | claude-haiku-5-5 | 0.000122 | 1A | 2026-02-20 | 2025-12-31 | 0001628280-26-010185 | false |
- Source and method
- Files
passages.parquet: the 10-K passagescells.parquet: the 10-K cellss_passages.parquet: AI within MD&Aq_passages.parquetandq_cells.parquet: the 10-Q follow-uprerun.parquet: the run-to-run checkmasked.parquet: the masked-prompt checkbaselines.parquet: per chunkcarryover.parquet: how much is copied from the year beforeembeddings.parquetandqueries.parquet: for redoing the retrievalchunks.parquet: the corpusgold_scores.parquetandlabels/companies.csvevents.csv,events_quarterly.csvandresults/
- Labels and agreement
- Known limitations
- How to load
- Versioning
- Licensing
S&P 500 10-K topic tone profiles, FY2019–FY2026
Data version 0.4.0 (exported 2026-10-18; changes since 0.1.0 under Versioning). provenance.json
records the version, the code commit, the model, hashes of the prompt and output schema, and the row
count of every table.
Tone scores for passages of S&P 500 10-K filings on five dimensions, toward 13 topics, by Claude
Haiku 5.5 (claude-haiku-5-5). The release also has FinBERT and Loughran-McDonald baselines on the
same passages, a 40-item human-labeled gold set with its adjudication, and every table the project's
published results are computed from. With these files, the project's events.py, diff.py report,
comove.py, charts.py and sentiment.py gold-report run with no SEC download, no embeddings and no API calls.
Since 0.4.0 the release also has the whole corpus (every chunk, not only the scored ones), its
embeddings and the topic query vectors, so the retrieval itself can be redone and extended without
fetching filings or calling an embedding API.
Results and method: the project's RESULTS.md and PLAN.md.
At a glance (2,683.6 MB in all; every file and column under Files):
| Part | Files | Rows | Size |
|---|---|---|---|
| Tone scores and analysis tables | passages, s_passages, q_passages, cells, q_cells, baselines, carryover, rerun, masked, gold_scores (.parquet), plus labels, event definitions and results |
126,051 scored 10-K passages, 42,017 cells | 25.5 MB |
| Corpus | chunks.parquet |
674,816 chunks | 158.5 MB |
| Embeddings | embeddings.parquet, queries.parquet |
674,816 vectors (1,024 floats each), 13 queries | 2,499.5 MB |
For the scores alone, download only the first part; passages.parquet is the main table.
Source and method
- Companies: the current S&P 500 constituents (498 after merging share classes), with GICS sector and sub-industry from the Wikipedia S&P 500 list.
- Filings: from SEC EDGAR. 10-K Item 1A (Risk Factors) and Item 7 (MD&A), 3,458 10-Ks for fiscal years 2019–2026. FY2026 has only the 74 companies whose fiscal year doesn't end in December. Also 10-Q MD&A for the 76 Financials companies, 1,700 10-Qs with quarters ending 2019-02-28 to 2026-06-30. Sections are split into chunks; a passage is one chunk.
- Cells and retrieval: a cell is one company, one 10-K and one topic (42,017 cells). Its
passages are hybrid search's top 3 within that 10-K, with no reranking. Hybrid search fuses vector
search (OpenAI
text-embedding-3-large, 1,024 dimensions) and BM25, the top 20 of each, by reciprocal rank fusion (k = 60). Each topic has one fixed query (provenance.json,topic_queries). Every topic is scored for every company; "Deposits and liquidity" is scored for Financials only. For AI, each 10-K's MD&A also has its own top 3, searched within it (s_passages.parquet). - Scorer:
claude-haiku-5-5, one call per passage and topic, through the Message Batches API. The prompt quotes the labeling rules (labels/guidelines.md) word for word. The model quotes its evidence before each score and sets an off-topic flag. The dimensions are:- polarity, −2 to +2: does the topic help or hurt?
- magnitude, 0–3: how big is the effect?
- realization, 0–2: has it happened?
- uncertainty, 0–3: how unpredictable are the effects?
- specificity, 0–2: how concrete?
- Baselines: FinBERT (
ProsusAI/finbert), the Loughran-McDonald Master Dictionary 1993–2025 and rule-based counts. They score the whole passage, not the topic. The dictionary itself is not included, only each passage's word shares. - Human labels: 40 passages labeled by one person, blind, then adjudicated (below).
Files
Row counts are for version 0.4.0; provenance.json has them for whichever version you hold.
Dates are ISO strings. ticker is the company's ticker in the current S&P 500 list, and fy is the
fiscal year as the company labels it.
| File | Rows | Size | What it is |
|---|---|---|---|
passages.parquet |
126,051 | 14.4 MB | Every scored 10-K passage |
s_passages.parquet |
10,308 | 0.4 MB | AI's top 3 within each 10-K's MD&A, scored |
cells.parquet |
84,034 | 1.7 MB | Every 10-K cell's mean scores, in two versions (42,017 each) |
q_passages.parquet |
10,196 | 1.2 MB | Every scored 10-Q passage (Financials) |
q_cells.parquet |
3,400 | 0.1 MB | Every 10-Q cell's mean scores |
rerun.parquet |
5,000 | 0.9 MB | 5,000 random 10-K passages scored a second time |
masked.parquet |
1,904 | 0.3 MB | Event-test passages scored again without the company and year |
baselines.parquet |
85,993 | 3.1 MB | FinBERT, LM and rule-based scores, one row per chunk |
carryover.parquet |
223,636 | 2.6 MB | Share of each 10-K chunk copied from the year before |
gold_scores.parquet |
40 | 0.02 MB | The model's scores of the 40 labeled items |
chunks.parquet |
674,816 | 158.5 MB | The corpus: text and metadata of every chunk, scored or not |
embeddings.parquet |
674,816 | 2,499.5 MB | Every chunk's embedding (1,024 floats), in chunks.parquet's order |
queries.parquet |
13 | 0.04 MB | The topic queries and their embeddings |
labels/ |
0.4 MB | Labeling rules, label sheets, adjudication | |
events.csv, events_quarterly.csv |
6, 2 | Event definitions, fixed before results | |
companies.csv |
503 | 0.03 MB | Company list: ticker, name, sector, sub_industry, cik |
results/ |
0.2 MB | The result tables the project's code writes | |
provenance.json, SHA256SUMS |
Versions and hashes; shasum -a 256 -c SHA256SUMS checks every file |
2,683.56 MB in all, almost all of it the embeddings. Without the corpus, the embeddings and the
*_evidence columns (the project's export --no-text), 10.44 MB.
passages.parquet: the 10-K passages
One row per passage. The key is (ticker, fy, topic, rank, chunk_id).
ticker,fy,topic: the cell.rank: 1–3, the passage's rank in the cell's hybrid search.chunk_id: the passage,{ticker}_{form}_{fy}_{item}_{seq}. One chunk can be in several cells.pid: the passage's row number in the project'sdata/tone/passages.parquet, which the project's score files are keyed by.orig_pidinrerun.parquetandmasked.parquetpoints to it. Across data versions, join on the key, not onpid: a new retrieval renumbers it.sector: the GICS sector.rrf: the passage's fused search score.off_topic: the model found nothing about the topic in the passage. Ignore the five scores on these rows. The project's results average over on-topic passages only.polarity,magnitude,realization,uncertainty,specificity: integer scores on the scales above.polarity_evidence, …,specificity_evidence: the words from the passage the model quoted for each score, or "" if none. This is model output that quotes filing text.model:claude-haiku-5-5.usd: the call's cost at batch price. The column sums to $18.94.item:1A(Risk Factors) or7(MD&A).filing_date,report_date(end of the fiscal year),accession(the SEC accession number).names_topic: whether the passage passes the word check, the regular expressions inprovenance.json(word_check). Only AI, China and tariffs have a word list; every other topic is True. The project's "word-checked" results keep only passages where this is True (see Limitations).
cells.parquet: the 10-K cells
One row per (ticker, fy, topic, version), computed by the project's events.cells().
sector,filing_date,report_date.- The five dimensions, plus the baselines
finbert_polarity,lm_polarity,lm_uncertaintyanddetails_per_100w: each one's mean over the cell's on-topic passages. They are empty when no passage is on topic. discussed: 1.0 if the cell has an on-topic passage, else 0.0. "Not discussed" is kept apart from neutral tone.version:modeluses every on-topic passage.word-checkeduses only those withnames_topic.
The cells cover the whole 10-K. Tests limited to one section, such as the section-by-section
results, start from passages.parquet and filter on item. For AI in MD&A, the project uses
s_passages.parquet instead (next section).
s_passages.parquet: AI within MD&A
The same columns as passages.parquet, for the topic AI only and Item 7 (MD&A) only: each 10-K's
top 3 passages searched within its MD&A, not over the whole 10-K. The ranking and query are the same
as for passages.parquet. There are 10,308 rows for the 3,436 10-Ks with an Item 7. The key is
(ticker, fy, topic, rank, chunk_id).
- Why: a whole-10-K cell has an MD&A passage only where MD&A out-ranks the risk factors, which happened less often as AI risk factors spread.
- Where it's used: the project's MD&A-only analyses of AI use these cells (
events.cells): the AI-boom test, the MD&A-alone tests, and the MD&A line of the AI charts. RESULTS.md §3 has the result. pid: the row number in the project'sdata/tone/s_passages.parquet. It is not comparable withpassages.parquet'spid.- Reused scores: 1,572 passages were already scored for the same cell in
passages.parquetand copied from there. Theirusdis 0 and theirbatchis the original one. The others cost $0.85, the sum ofusd. names_topic: as inpassages.parquet; 857 rows name AI.
q_passages.parquet and q_cells.parquet: the 10-Q follow-up
The same columns as the 10-K files, for the 76 Financials companies' 10-Q MD&A (item = mdna) and
two topics, deposits and liquidity, and interest rates. The key is (ticker, report_date, topic,
rank, chunk_id); report_date is the end of the quarter. There is no Q4, because the Q4 report
is the 10-K. There is no names_topic column and no word-checked version, since these two topics
have no word list.
rerun.parquet: the run-to-run check
The same request, sent again for 5,000 random 10-K passages. It has the same columns as
passages.parquet, without names_topic. orig_pid points to the first run's row in
passages.parquet (its pid). It is −1 for one passage, which the fiscal-year fix moved out of
its cell's top 3; 4,999 still match. Rows are in the order of the project's rerun_passages.parquet.
masked.parquet: the masked-prompt check
1,904 passages from the annual event tests' "before" and "after" cells, scored again with the
company and fiscal year taken out of the prompt. The Filing line reads "Filing: a 10-K, Item 1A Risk
Factors" instead of naming them (tone.masked_prompt). Its template's hash is
masked_user_prompt_template_sha256 in provenance.json, apart from prompt_key. The sample was
drawn under the filed "before" rule. It leaves out the 13 companies whose fiscal-year labels were
then being fixed. Costs: usd sums to $0.27. RESULTS.md §3 has the result.
- The columns of
rerun.parquet, plus:event: the event whose test the passage was drawn for;cell:beforeorafter;group:affectedorothers.
orig_pidis −1 for one passage (DOW, FY2022, interest rates), which dropped out of the rankings after the fiscal-year fix; 1,903 still match.- Rows are in the order of the project's
masked_passages.parquet.
baselines.parquet: per chunk
One row per chunk_id in chunks.parquet. Each baseline scores the whole passage, not the topic.
finbert_polarity: the mean over sentences of P(positive) − P(negative).finbert_negative,finbert_positive: the share of sentences whose top label is negative or positive.lm_negative,lm_positive,lm_uncertainty,lm_litigious,lm_strong_modal,lm_weak_modal,lm_constraining: each Loughran-McDonald category's share of the passage's words that are in the master dictionary.lm_polarity:lm_positive−lm_negative.details_per_100w: amounts, percentages, years and product codes per 100 words, a rough specificity proxy.hedges_per_100w,realized_per_100w: hedge words and realized-event cues per 100 words.
carryover.parquet: how much is copied from the year before
One row per chunk of every 10-K that has the same company's 10-K for the year before.
chars: the chunk's characters.carried: the characters in sentences that closely match (difflibratio ≥ 0.9) a sentence of the same item in that earlier 10-K.share:carried/chars.ticker,sector,fy,item.
It covers all such chunks, not only the scored passages, so the filing-level carryover table can be recomputed.
embeddings.parquet and queries.parquet: for redoing the retrieval
embeddings.parquet:chunk_idandembedding, a fixed-size list of 1,024 float32 values. One row per row ofchunks.parquet, in the same order. These are the vectors the project searched: OpenAItext-embedding-3-largeat 1,024 dimensions, embedded as plain text, scaled to unit length. So a dot product is the cosine similarity.queries.parquet:topic,query(the fixed text, as inprovenance.json) andembedding, the vector each cell was ranked with. Embedding a query again can give a slightly different vector, so use these to reproduce the cells exactly.- What they let you do: with the corpus, this redoes the project's retrieval with no API call: exact
cosine over the embeddings and BM25 (
bm25s) over all chunks, each list's top 20 within the filing, fused by RRF (k = 60), top 3. The project'stone.pydoes this. From this release alone, it reproduced every AI cell ofpassages.parquetand all ofs_passages.parquetexactly (checked 2026-10-18). Searching for a new query needs that query embedded with the same model.
chunks.parquet: the corpus
Every chunk the project searched, scored or not: 10-K Item 1A and Item 7, and the Financials' 10-Q
MD&A. Rows are in the project's order, the same as embeddings.parquet. (Until 0.3.0 it held only
the chunks of scored passages.) Its columns are those of the project's data/chunks.parquet:
chunk_id,ticker,sector,form,item,fy,report_date,filing_date,accession.period_quarter: the calendar quarter ofreport_date.seq: the chunk's position in its section.heading: the heading the chunk falls under.text: the passage as extracted from the filing.n_tokens: the passage's length incl100k_basetokens.
gold_scores.parquet and labels/
gold_scores.parquet: the model's scores (with evidence) of the 40 labeled items, joined onitem_id. Same model, prompt, schema and effort as the full run, sent one call at a time rather than batched.labels/guidelines.md: the labeling rules, frozen before the gold set was labeled. The scorer's prompt quotes them word for word.labels/HOW_TO_LABEL.md: the walkthrough for human labelers.labels/practice.csv: 10 hand-picked practice passages (P01–P10) with the labeler's labels.labels/practice_blind.csv: the same labels as first made. They differ frompractice.csvin one score, which is off the scale (P02's realization of 3), and in howoff_topicis written.labels/practice_key.csv: the practice sheet's reference scores, with reasons.labels/gold_profiles.csv: 30 passages (G01–G30) drawn at random the way the full run picks passages, labeled blind.labels/gold_adjudication.csv: one row per item and field where the blind label and the model disagreed (85 rows). It has the labeler's label, the model's label and evidence, thefinallabel after review, and a note.
The sheets include each passage's text (passage column).
companies.csv
The S&P 500 list as fetched once from Wikipedia. It has 503 rows, one per ticker, including both
share classes. The columns are ticker, name, GICS sector and sub_industry, and the SEC cik.
The event tests read sub_industry to find the affected companies, such as semiconductors for the
export controls. In the project it sits at data/companies.csv.
events.csv, events_quarterly.csv and results/
events.csv and events_quarterly.csv define the events. Each row has the event date and, where
"after" starts later, an after date. It names the affected sectors and sub_industries, the
topics and items, and an expected direction (+, - or empty) per dimension, with a note. All
were fixed before the results.
results/ holds the tables the project's code writes, copied unchanged. The annual tests compare
each company's last 10-K whose fiscal year ended before the event with its first 10-K whose fiscal
year ends on or after it. This is the "one-year rule", primary since 2026-10-17. The earlier rule
took the last 10-K filed before the event. Its results are events_filed*.csv.
| File | Contents | RESULTS.md section |
|---|---|---|
events.csv, events_named.csv |
Event tests, model only and word-checked (one-year rule) | §3, §4 |
events_filed.csv, events_filed_named.csv |
The same, under the filed rule (events.py --filed) |
§3 |
events_1A*.csv, events_7*.csv |
The same tests on each section alone | §3 |
event_study*.csv, event_breaks*.csv |
Every fiscal year around each event, and the break check | §3 |
events_new*.csv |
Event tests on new (not copied) passages only | §8 |
events_whole.csv, events_whole_named.csv |
The record of events*.csv before the AI boom used s_passages.parquet: its MD&A cells were the MD&A part of the whole-10-K top 3 |
§3 |
events_v1.csv |
The first version of the event tests, before the design changes listed in Limitations | Limitations |
q_events.csv |
The 10-Q event tests: "before" is the last 10-Q filed before the event, as events_quarterly.csv defines |
§6 |
comove.csv |
Sector co-movement | §9 |
Each event-test row covers one event and one measure. It has the expected direction, the companies
counted, and for the affected group, the others and their difference (did): the estimate, a 95%
bootstrap interval (_lo, _hi) and its sign.
Labels and agreement
Copied from RESULTS.md §1–§2 (2026-10-18).
40 passages (10 hand-picked practice items, 30 drawn at random the way Phase 9 picks passages), labeled by one person, blind, then reviewed where they and the model disagreed.
| Blind labels | After review | |
|---|---|---|
| Off topic | model flagged 11, person 0; all 11 are off topic on inspection | 11 of 11 |
| Polarity (kappa) | −0.08 [−0.39, +0.26] | 0.20 |
| Magnitude | 0.12 [−0.10, 0.38] | 0.72 |
| Realization | 0.67 [0.33, 0.88] | 0.90 |
| Uncertainty | 0.52 [−0.02, 0.78] | 0.90 |
| Specificity | 0.50 [0.10, 0.81] | 1.00 |
Weighted kappa on the 20 random items both call on topic; 0.6 was the threshold fixed in advance.
- What holds: the off-topic flag, confirmed by hand (none of the 11 passages contains a word for its topic), and realization, which passes on blind labels.
- Why the rest is open: the blind labels scored what each passage says rather than what it says about the topic, which depresses agreement; and in review, 67 of 85 disagreements were settled by adopting the model's label, which raises agreement by construction. Neither column is a clean measure. Polarity can't be judged at all: the model gives −1 to 18 of 20 items.
Full run:
All 126,051 passages scored, none failed, $18.94 (a smoke test on one company first, $0.05). That includes the fiscal-year fix (2026-10-17): 501 new passages scored and 968 rescored because their request named the wrong fiscal year, for $0.21; $18.94 is what the kept scores cost, and $19.09 was paid in all.
24.8% of passages are off topic, and 10% of cells have no on-topic passage ("topic not discussed", kept apart from neutral tone). Rare topics are off topic most often: AI 62%, China 60%, tariffs 53%, against government policy 1% and demand 4%.
Score spread on on-topic passages:
Dimension Distribution Polarity −2: 5%, −1: 86%, 0: 5%, +1: 4%, +2: 1% Magnitude 0: 27%, 1: 42%, 2: 29%, 3: 2% Realization 0: 47%, 1: 22%, 2: 31% Uncertainty 0: 9%, 1: 3%, 2: 78%, 3: 9% Specificity 0: 10%, 1: 32%, 2: 58% Polarity barely varies, as the project's premise expects for risk language that is negative by design. Realization varies the most.
Run-to-run stability (B6, 2026-10-17, $0.79): 5,000 random passages scored a second time with the same request (4,999 still match a passage after the fiscal-year fix; recomputed 2026-10-18). The off-topic flag agrees on 97.6%. On passages both runs call on topic:
Dimension Identical Weighted kappa Polarity 95% 0.89 [0.87, 0.91] Magnitude 75% 0.78 [0.76, 0.79] Realization 85% 0.88 [0.87, 0.89] Uncertainty 94% 0.89 [0.87, 0.91] Specificity 86% 0.84 [0.83, 0.85]
Known limitations
- The off-topic flag is lenient. The gold set confirmed that passages the model flags as off topic
are off topic. The reverse error was never measured. RESULTS.md (Limitations) checked it with topic
words: of the passages called on topic, those not naming the topic are 52–58% for AI in
FY2019–FY2022 (15% in FY2023, 3% in FY2025), 20–23% for tariffs until FY2023 (6% in FY2025) and
20–26% for China in every year (rechecked 2026-10-18). Use
names_topicor theword-checkedcells for these three topics. The other topics have no clear vocabulary to check. - Survivorship bias. The companies are today's S&P 500. That leaves out companies that dropped out or went bankrupt, which leans the sample toward companies that did well (PLAN.md, Risks).
- One labeler. One person labeled the gold set, with no second rater. The adjudicated labels lean toward the model, so they can't validate it.
- Magnitude is below the run-to-run bar. Scored twice, the same passage gets the same magnitude 75% of the time (weighted kappa 0.78, under the 0.8 bar set in advance). Averages over many companies absorb that, but single-company magnitude changes are half scorer noise.
- The scorer is told the company and fiscal year, so the event tests are free of labels but not
of the model's knowledge of what happened when. The baselines see only the text. Masking both
(1,904 event-test passages, $0.27; RESULTS.md §3) leaves realization's changes intact but removes most
of COVID's rise in uncertainty (+0.21 → +0.02), which came from FY2019 passages scored as calmer
when labeled FY2019. The masked scores are
masked.parquet. - A cell is 3 passages. Which 3 are retrieved can change from year to year (RESULTS.md §9). In the 10-Qs, the top 3 for a fixed topic query favor sections that recur every quarter, so event text is often not scored (RESULTS.md §6).
- Fiscal years are the companies' own. Most end in December; NVDA's ends in January.
- Data versions differ. 0.2.0 corrected 13 companies' fiscal-year labels (Versioning). That
changed some cells and renumbered
pid: only 0.7% of 0.1.0'spids point to the same passage in 0.2.0. Comparedata_versionbefore comparing numbers across releases. - Extraction gaps. A few sections are missing or cut, such as Deere's 10-K MD&A in every year (PLAN.md, Notes).
How to load
import pandas as pd
p = pd.read_parquet("passages.parquet")
on = p[~p.off_topic] # scores count only on on-topic passages
cell = on.groupby(["ticker", "fy", "topic"])[["polarity", "realization"]].mean()
c = pd.read_parquet("cells.parquet").query("version == 'model'") # the same cell means, precomputed
text = pd.read_parquet("chunks.parquet", columns=["chunk_id", "text"])
p = p.merge(text, on="chunk_id")
With Hugging Face datasets, by config name from the header:
from datasets import load_dataset
p = load_dataset("milosand1/sec-filings-tone", "passages", split="train")
s = load_dataset("milosand1/sec-filings-tone", "s_passages", split="train") # AI within MD&A
To rerun the project's code on this release, rebuild its working files from a clone of the
repository. Then run the commands in RESULTS.md's "Reproduce" section, from events on. This
recipe was checked on version 0.2.0. From it, events (plain, --named, --robust, --filed),
diff report and comove rewrote 15 of the 17 files in results/ with identical numbers. On
0.3.0, with s_passages.parquet added to the recipe, events and events --named were rechecked
and matched exactly. events_whole*.csv came from code before 0.3.0. On 0.2.0, two files didn't match:
events_v1.csvcame from earlier code.q_events.csvdiffers slightly, with the same verdicts. The project'sevents.py --quarterlynow uses the one-year rule, while the file (and RESULTS.md §6) uses the filed rule thatevents_quarterly.csvdefines.events.report(*events.QUARTERLY[:2], filed=True)reproduces it exactly.
sentiment gold-report (blind and --adjudicated) printed the agreement tables above.
tone.masked_report() printed the same output as on the project's own files.
import pandas as pd
from pathlib import Path
R, t = Path("path/to/release"), Path("data/tone")
t.mkdir(parents=True, exist_ok=True)
dims = ["polarity", "magnitude", "realization", "uncertainty", "specificity"]
scores = ["pid", "off_topic", *[c for d in dims for c in (f"{d}_evidence", d)], "model", "usd"]
for pre, cols in [("", ["ticker", "sector", "fy", "topic", "rank", "chunk_id", "rrf"]),
("s_", ["ticker", "sector", "fy", "topic", "rank", "chunk_id", "rrf"]),
("q_", ["ticker", "sector", "fy", "report_date", "topic", "rank", "chunk_id", "rrf"])]:
x = pd.read_parquet(R / f"{pre}passages.parquet").sort_values("pid") # pid = row number
x[cols].to_parquet(t / f"{pre}passages.parquet", index=False)
x[scores].to_parquet(t / f"{pre}scores.parquet", index=False)
pd.read_parquet(R / "baselines.parquet").to_parquet(t / f"{pre}baselines.parquet", index=False)
base = ["orig_pid", "ticker", "sector", "fy", "topic", "rank", "chunk_id", "rrf"]
for name, cols in [("rerun", base), ("masked", [*base, "item", "filing_date", "report_date", "cell", "event", "group"])]:
x = pd.read_parquet(R / f"{name}.parquet").reset_index(names="pid") # rows in the project file's order
x[cols].to_parquet(t / f"{name}_passages.parquet", index=False)
x[scores].to_parquet(t / f"{name}_scores.parquet", index=False)
pd.read_parquet(R / "carryover.parquet").to_parquet(t / "carryover.parquet", index=False)
pd.read_parquet(R / "chunks.parquet").to_parquet("data/chunks.parquet", index=False)
# for sentiment.py gold-report: data/sentiment/gold_scores_claude-haiku-5-5.parquet <- gold_scores.parquet
# optional, to redo the retrieval (tone.py retrieve --section, check): the embeddings and query vectors
import numpy as np, pyarrow.parquet as pq
from sec_filings_tone.tone import QUERIES, VECTOR_ORDER, order_hash
e = pq.read_table(R / "embeddings.parquet")
np.save(t / "vectors.npy", e.column("embedding").combine_chunks().flatten().to_numpy().reshape(len(e), -1))
VECTOR_ORDER.write_text(order_hash(e.column("chunk_id").to_pandas()))
QUERIES.parent.mkdir(parents=True, exist_ok=True)
np.save(QUERIES, np.stack(pd.read_parquet(R / "queries.parquet").embedding))
charts.py writes into the repository's figures/. Since 0.4.0, diff.py carryover can be rerun
too, since chunks.parquet has every 10-K chunk.
Versioning
data_version follows MAJOR.MINOR.PATCH. The minor number goes up whenever any score, passage
or row changes (0.2.0 for the fiscal-year fix). 1.0.0 is the version frozen for the paper. The same
version string is in this card's header, in provenance.json and in the release's name wherever it
is published. A later Hugging Face or Zenodo copy names the version it holds, so it can be traced to
the GitHub copy.
provenance.json also has a prompt_key: a short hash of the system prompt, the output schema and
the user-prompt template. Scores made later with a different prompt will have a different key.
- 0.1.0 (2026-10-17): first export.
- 0.4.0 (2026-10-18):
- The whole corpus.
chunks.parquetnow has every chunk, 674,816, not only the 85,993 of scored passages. - New tables.
embeddings.parquethas every chunk's embedding.queries.parquethas the topic query vectors the cells were ranked with. - Nothing else changed. Every other table, score and result is as in 0.3.0.
- The whole corpus.
- 0.3.0 (2026-10-18):
- New table.
s_passages.parquet: AI's top 3 searched within each 10-K's MD&A, 10,308 passages; 8,736 newly scored for $0.85, and 1,572 scores copied frompassages.parquet.baselines.parquetandchunks.parquetgain their 6,521 new chunks. - Results. In
results/events*.csv,event_study*.csvandevents_new*.csv, only the AI-boom rows changed.events_whole*.csvkeeps the earlier AI-boom results as the record. The other tables are rebuilt from the same project files as 0.2.0.
- New table.
- 0.2.0 (2026-10-18):
- Fiscal-year fix. 13 companies' 10-Ks were relabelled: AVY, CDNS, DPZ, ILMN, JNJ, LDOS, LHX,
RVTY, SNA, SWK, TDY, TRMB and TXT. 13 10-Ks that had been lost were recovered. The release now
has 126,051 passages, 42,017 cells and 3,458 10-Ks; the project's chunks table has 674,816 rows.
The
usdcolumn now sums to $18.94: 501 passages are new, and 968 were rescored because their prompt had named the wrong fiscal year. - Event rule. The one-year "before" rule is now primary for
results/events*.csv,event_breaks*,event_study*andevents_new*. The filed rule's results areresults/events_filed*.csv. Theevents_fyrule*.csvfiles are gone, since they were identical to the new primary. - New table.
masked.parquet, the masked-prompt check. - One passage no longer matches. One row of
rerun.parquetand one ofmasked.parquethaveorig_pid−1. - Smaller fixes.
baselines.parquetkeeps only chunks inchunks.parquet. The prompt, schema andprompt_keyare unchanged.
- Fiscal-year fix. 13 companies' 10-Ks were relabelled: AVY, CDNS, DPZ, ILMN, JNJ, LDOS, LHX,
RVTY, SNA, SWK, TDY, TRMB and TXT. 13 10-Ks that had been lost were recovered. The release now
has 126,051 passages, 42,017 cells and 3,458 10-Ks; the project's chunks table has 674,816 rows.
The
Licensing
The scores, cells, baselines, labels and result tables are released under CC BY 4.0. Some parts come from third parties and stay under their own terms:
- Filing text (
chunks.parquet, the*_evidencecolumns, thepassagecolumn of the label sheets): excerpts of 10-K and 10-Q filings, public documents on SEC EDGAR, written by the filing companies. - LLM outputs (all scores and quoted evidence): made with Anthropic's API, under its terms.
- Loughran-McDonald: the dictionary is not included, only per-passage word shares derived from it. Its authors make it free for academic use.
- FinBERT (
ProsusAI/finbert): only its outputs are included, under the model's license. - Embeddings (
embeddings.parquet,queries.parquet): made with OpenAI's API (text-embedding-3-large), under its terms. - Sector and sub-industry columns: from Wikipedia's S&P 500 list, under CC BY-SA. GICS is a trademark of MSCI and S&P.
Nothing here is a legal conclusion.
- Downloads last month
- 76